Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular Diagnostic Program for Early Screening of Colorectal Cancer in China

ABSTRACT: Interventions: Gold Standard:Pathological diagnosis;Index test:Early screening model of colorectal cancer Primary outcome(s): Sensibility;Specificity;Positive Predictive Value;Negative Predictive Value;Tissue Biomarker Methylation;Tissue Biomarker Mutation;Blood Biomarker Methylation;Stool Mutation;Stool Methylation;Stool Bacteria Study Design: Sequential

DISEASE(S): Colorectal Cancers In China

PROVIDER: 2688309 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Application value of multi-target stool FIT-DNA test (ColoClear) in patients with early colorectal cancer and precancerous lesions and their first-degree relatives: a prospective study

Project description:Interventions: Gold Standard:Colonoscopy.;Index test:Multi-target stool FIT-DNA test (ColoClear). Primary outcome(s): Sensitivity;Specificity;Positive predictive value;Negative predictive value Study Design: Cohort study

| 2725412 | ecrin-mdr-crc

A prospective study on the application of Multi-target Stool FIT-DNA Test (ColoClear) in colorectal cancer screening and the practical verification of genetic and lifestyle factors

Project description:Interventions: Gold Standard:colonoscopy;Index test:Multi-target Stool FIT-DNA Test (ColoClear) ; Fecal immunochemical test(Pupu Tube) Primary outcome(s): Sensitivity;Specificity;Positive predictive value;Negative predictive value;Coincidence Rate;Morbidity Study Design: Cohort study

| 2662204 | ecrin-mdr-crc

Performance of new biomarkers and technologies for colorectal cancer screening

Project description:Interventions: Gold Standard: Taking colonoscopy together with pathological examination results as the gold standard.;Index test:Detection of miR-92a in stool samples; Detection of Septin9 in plasma samples; Detection of FIT-DNA in stool samples; Fecal immunochemical test. Primary outcome(s): Sensitivity;Specificity;Positive predictive value;Negative predictive value Study Design: Diagnostic test for accuracy

| 2662086 | ecrin-mdr-crc

Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2 Methylation Test in China

Project description:The primary objective is to determine sensitivity, specificity, positive predictive value and negative predictive value of a bi-target stool DNA testing (the methylation status of SDC2 and SFRP2) for colorectal cancer and advanced precancerous neoplasm(including advanced adenoma and advanced serrated lesions) screening, using colonoscopy as the reference method. Lesions will be confirmed as malignant or precancerous by histopathologic examination. The secondary objective is to compare the performance of the bi-target stool DNA testing to a commercially available fecal immunochemical test (FIT) assay, both with respect to cancer and advanced precancerous neoplasm. Lesions will be confirmed as malignant or precancerous by colonoscopy and histopathologic examination.

| 2348965 | ecrin-mdr-crc

the study of the diagnostic value of DNA methylation in blood and stool in colorectal cancer

Project description:Interventions: Gold Standard:Colonoscopy biopsy;Index test:detection of novel DNA methylation sites in stool and blood Primary outcome(s): Deoxyribonucleic acid methylation status and blood Study Design: Sequential

| 2716875 | ecrin-mdr-crc

Artificial intelligence assisted endocytoscopy in real-time diagnosis of early colorectal cancer

Project description:Interventions: Gold Standard:Pathological test;Index test:1. Endoscopy; 2. Artificial intelligence real-time diagnosis system. Primary outcome(s): Diagnostic accuracy;Sensitivity;Specificity;Positive predictive value;Negative predictive value Study Design: Sequential

| 2725610 | ecrin-mdr-crc

Clinical study of fecal SDC2 / TFPI2 methylation combined with FIT in the detection of colorectal cancer and precancerous lesions

Project description:Interventions: Gold Standard:colonoscopy/pathological diagnosis;Index test:fecal SDC2 / TFPI2 methylation combined with FIT Primary outcome(s): fecal SDC2 / TFPI2 methylation;stool occult blood test;colonoscopic results;pathologic results Study Design: Factorial

| 2725740 | ecrin-mdr-crc

Stool DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer

Project description:Interventions: Gold Standard:colonoscopy;Index test:Stool DNA methylation biomarkers. Primary outcome(s): accuracy Study Design: Diagnostic test for accuracy

| 2680588 | ecrin-mdr-crc

Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods

Project description:This project is the first application, which is applied as a single center project and applied according to the screening quantity. This project is a multi-omics approach to explore biomarkers associated with prognosis after secondary radical resection of recurrent and metastatic colorectal cancer. Main research objectives: 1. To detect DNA mutation and methylation in tumor tissues by NGS detection technology (the methylation dimension should be detected in adjacent tissues at the same time), and to explore specific molecular markers related to prognosis; 2. Using NGS test technology of blood in patients with preoperative and postoperative blood ctDNA mutations and methylation double dimension testing, respectively, to explore the preoperative and postoperative ctDNA mutations and the correlation between methylation status and recurrence, including but not limited to predict patients with recurrence of sensitivity, specificity, positive predictive value, negative predictive value and recurrence warning time and other indicators. Main contents: This study intends to include single site for the first time/organ metastasis after radical treatment and surgical indications again in patients with colorectal adenocarcinoma (including but not limited to spread to the liver, lung metastasis, peritoneal metastasis, lymph node metastasis and other organ metastasis), collected in patients with preoperative peripheral blood and tissue samples, tissue adjacent to carcinoma and postoperative peripheral blood, NGS detection technology was used to detect DNA and mutation in the relevant samples, combined with clinical treatment and prognosis information of patients, and then explore biomarkers for predicting recurrence risk.

| 2745213 | ecrin-mdr-crc

Altered fecal small RNA profiles in colorectal cancer reflect gut microbiome composition in stool samples

Project description:Dysbiotic configurations of the human gut microbiota have been linked with colorectal cancer (CRC). Human small non-coding RNAs are also implicated in CRC and recent findings suggest that their release in the gut lumen contributes to shape the gut microbiota. Bacterial small RNAs (bsRNAs) may also play a role in carcinogenesis but their role is less explored. Here, we performed small RNA and shotgun sequencing on 80 stool specimens of patients with CRC, or adenomas, and healthy subjects collected in a cross-sectional study to evaluate their combined use as a predictive tool for disease detection. We reported a considerable overlap and correlation between metagenomic and bsRNA quantitative taxonomic profiles obtained from the two approaches. Furthermore, we identified a combined predictive signature composed by 32 features from human and microbial small RNAs and DNA-based microbiome able to accurately classify CRC from healthy and adenoma samples (AUC= 0.87). In summary we reported evidence that host-microbiome dysbiosis in CRC can be observed also by altered small RNA stool profiles. Integrated analyses of the microbiome and small RNAs in the human stool may provide insights for designing more accurate tools for diagnostic purposes.

2019-08-30 | GSE132236 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data